Slide 1: oat Y
oat Y
Slide 2: Disclaimer
DISCLAIMER This presentation also contains estimates and other statistical data made by independent parties and by the Company relating to market size the concentration of our voting power as a result of our dual class structure; our status as a foreign private issuer; and other risk factors set and
Slide 3: Our vision is to transform the global beauty & wellness market
OUR VISION IS TO TRANSFORM THE GLOBAL BEAUTY & WELLNESS MARKET THROUGH ISRAELI TECHNOLOGY & ENTREPRENEURIAL THINKING FOR THE BENEFIT OF CONSUMERS ALL OVER THE WORLD. 3
Slide 4: Our platform: powerhouse brands with shared technology and shared data
OUR PLATFORM: POWERHOUSE BRANDS WITH SHARED TECHNOLOGY + SHARE DATA 4
Slide 5: Large global TAM with deep competitive moats
LARGE GLOBAL TAM WITH DEEP COMPETITIVE MOATS $600B+ Total Beauty & Wellness1 Skin Care Hair Care Color Cosmetics GLOBAL ADDRESSABLE MARKET ODDITY VS LEGACY MODELS Source: Euromonitor 2022 Note: 1. Defined as the global beauty and personal care and dietary supplements market, per Euromonitor, in 2022
Slide 6: $ODD financial highlights
$ODD FINANCIAL HIGHLIGHTS $479M $94M $164M Net revenue, Adjusted EBITDA1, Cash, ST investments, LTM LTM & restricted cash, Q323 +54% 20% $97M YoY net revenue Adjusted EBITDA2 Free-cash flow3, growth, LTM margin, LTM LTM Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is no
Slide 7: A rare combination of scale, growth and profitability
A RARE COMBINATION OF SCALE + GROWTH + PROFITABILITY +60% +52% NET REVENUE GROWTH +105% $411M $257M $169M NET REVENUE $91M ADJUSTED EBITDA1 $34M $37M 9mo 2021 9mo 2022 9mo 2023 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance w
Slide 8: Q3 2023 results stronger than expected
Q3 2023 RESULTS STRONGER THAN EXPECTED Q3 2023 GUIDANCE ACTUAL (issued August) NET REVENUE 37% 18 to 23% GROWTH GROSS MARGIN 70.3% 67.5% ADJUSTED EBITDA 22.0% 20.0 to 21.5% MARGIN ADJUSTED $0.21 $0.13 to 0.15 DILUTED EPS Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is n
Slide 9: Raising 2023 full year outlook
RAISING 2023 FULL YEAR OUTLOOK FY2023 UPDATED PREVIOUS GUIDANCE GUIDANCE (Aug) NET REVENUE 52 to 53% / 46 to 48% / GROWTH / $ $493 to 497mn $475 to 480 GROSS MARGIN 70.0% 69.5% ADJUSTED EBITDA 21.0% / 20.0 to 21.0% / MARGIN / $ $104 to 105mn $96 to 101mn ADJUSTED $1.21 to 1.23 $1.11 to 1.17 DILUTED
Slide 10: Q3 2023 highlights
Q3 2023 HIGHLIGHTS In millions Q3 2023 vs Q3 2022 Net Revenue $94.5 +37% Gross Margin 70.3% +217 bps Adjusted EBITDA $20.8 +227% Adjusted EBITDA margin 22.0% +1280 bps Adjusted Diluted EPS $0.21 +198% Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or p
Slide 11: 9MO 2023 highlights
9MO 2023 HIGHLIGHTS In millions 9mo 2023 vs 9mo 2022 Net Revenue $411.4 +60% Gross Margin 70.7% +300 bps Adjusted EBITDA $91.0 +147% Adjusted EBITDA margin 22.1% +779 bps Adjusted Diluted EPS $1.14 +139% Free-cash flow $78.0 +352% Note: 1. Adjusted EBITDA is a supplemental measure of our performance
Slide 12: Appendix
APPENDIX 12
Slide 13: Reconciliation of net income to Adjusted EBITDA
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA Year Ended Nine Months Ended December 31, September 30, ($ in millions) 2020 2021 2022 2022 2023 Net Income $11.7 $13.9 $21.7 $22.4 $53.4 % Margin 11% 6% 7% 9% 13% Adjusted to exclude the following: Financial Expenses (Income), Net 1.3 0.9 -1.2 -1.5 -2
Slide 14: Reconciliation of net cash from operating activities to free cash flow
Reconciliation of Net Cash from Operating Activities to Free Cash Flow Year Ended December 31, Nine Months Ended September 30, ($ in thousands) 2021 2022 2022 2023 Net Cash From Operating Activities $ 10 $ 39 $ 19 $ 80 Purchase of PP&E (2) (2) (2) (2) Free Cash Flow1 $8 $ 37 $ 17 $78 Free Cash Flow